Company Overview
- Headquarters
- 777 Taylor St., Fort Worth TX
- Website
- xequel.com
- Employees
- 14
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Xequel Bio
Xequel Bio, Inc. is a clinical stage biopharmaceutical company headquartered in Fort Worth, Texas. The company employs 14 people. Xequel Bio focuses on developing drugs utilizing its proprietary aCT1 technology platform. This platform aims to address inflammation and the body's response to injury. Their lead clinical programs include Granexin® gel, targeted towards dermatological conditions, and iNexinTM ophthalmic solution, designed for ophthalmological applications. Additionally, the company conducts preclinical research in pulmonology. Xequel Bio's aCT1 technology is a patented new chemical entity currently undergoing development for various medical applications. Visit Xequel Bio's website at xequel.com for more information.
Xequel Bio Industry Tags
Companies Similar to Xequel Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Xequel Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |